L. Verbist
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 39
- Co-authors
- Jan VerhaegenGert A. VerpootenMarc E. De BroeRubén A. GiulianoRené VerbesseltJohan Van EldereP.J. De SchepperJohan Maertens
- Journals
- Antimicrobial Agents and Chemotherapy (17 papers)Journal of Antimicrobial Chemotherapy (14 papers)European Journal of Clinical Microbiology & Infectious Diseases (5 papers)Drugs (4 papers)Diagnostic Microbiology and Infectious Disease (3 papers)
- Partner nations
- BelgiumIsraelNetherlands
In The Last Decade
L. Verbist
119 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 686
- Applied Microbiology and Biotechnology 173
- Pharmacology 1.1k
- Infectious Diseases 894
- Clinical Biochemistry 323
Countries citing papers authored by L. Verbist
This map shows the geographic impact of L. Verbist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Verbist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Verbist more than expected).
Fields of papers citing papers by L. Verbist
This network shows the impact of papers produced by L. Verbist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Verbist. The network helps show where L. Verbist may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Verbist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Platelet rich plasma (PRP) to prevent amniotic fluid leakage after fetoscopic interventions: an in vitro study in a human amniochorion explant culture on a PRP matrix | 2005 | 1 |
| 2 | Pathways of decidual infiltration by trophoblast at the placental-decidual junction in the rat | 2003 | 3 |
| 3 | Growth factors in fetal membrane healing: evaluation using confluent cultures of amnion derived epithelial (WISH) cells | 2002 | 4 |
| 4 | Sealing fetal membrane defect using microfibrillar collagen, liquid polyethyleneglycol (PEG) or a mixture of both: evaluation in vitro in organ cultures and in vivo in the rabbit | 2002 | 1 |
| 5 | Interstitial trophoblast invasion of the mesometrial triangle is a prominent feature of placentation in the rat | 2001 | 3 |
| 6 | 2000 | 20 | |
| 7 | Relative contribution of interstitial and endovascular trophoblast to elastica breakdown in placental bed spiral arteries | 1999 | 7 |
| 8 | 1998 | 18 | |
| 9 | 1995 | 2 | |
| 10 | 1995 | 1 | |
| 11 | 1994 | 3 | |
| 12 | Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group. | 1993 | 35 |
| 13 | 1992 | 31 | |
| 14 | 1991 | 1 | |
| 15 | 1991 | 13 | |
| 16 | 1991 | 63 | |
| 17 | 1990 | 98 | |
| 18 | 1990 | 1 | |
| 19 | 1981 | 3 | |
| 20 | Rifampicin activity "in vitro" and in established tuberculosis in mice. | 1969 | 21 |
About L. Verbist
L. Verbist is a scholar working on Molecular Medicine, Drug Discovery, Applied Microbiology and Biotechnology, Pharmacology and Transplantation, having authored 127 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (47 papers), Antibiotic Resistance in Bacteria (39 papers), Pneumonia and Respiratory Infections (15 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Tuberculosis Research and Epidemiology (11 papers), Antibiotic Use and Resistance (9 papers), Mycobacterium research and diagnosis (8 papers) and Bacterial Infections and Vaccines (7 papers). The work is most often cited by research in Molecular Medicine (686 citations), Applied Microbiology and Biotechnology (173 citations), Pharmacology (1.1k citations), Infectious Diseases (894 citations) and Clinical Biochemistry (323 citations). L. Verbist has collaborated with scholars based in Belgium, Israel and Netherlands. Frequent co-authors include Jan Verhaegen, Gert A. Verpooten, Marc E. De Broe, Rubén A. Giuliano, René Verbesselt, Johan Van Eldere, P.J. De Schepper, Johan Maertens, Gregor Verhoef and Marc Boogaerts. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Drugs and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.